AutoCRAT is a Horizon 2020 Project focused on:
Repairing Damage
Repairing Damage
AutoCRAT will explore using articular chondrocytes (cartilage cells) to help repair damage to joints.
Preventing & Treating OA
Preventing & Treating OA
AutoCRAT will explore using mesenchymal stromal cells (MSC) and extracellular vesicles (EVs) to prevent and to treat OA.Generating Cells
Generating Cells
AutoCRAT will generate sustainable sources of cells ready for therapeutic use.
Automated Production
Automated Production
AutoCRAT will build a Regenerative Medicine Factory for cost-effective, controlled, automated manufacture of therapeutic products in line with regulations.
The AutoCRAT Team
The AutoCRAT consortium is made up of the following partners:
Find out more about the Team here.
Latest News
Read all about our news, project updates and announcements on our news page.
Prof. Anders Lindahl discusses his work in AutoCRAT in ATMP World Tour segment
University of Gothenburg PI Professor Anders Lindahl introduced and interviewed Bernard Siegel, JD for an ATMP World Tour 2024 segment. The piece aired on April 23rd, 2024. As a recognized policy expert on stem cell research, regenerative [...]
AutoCRAT results avalanche at OARSI 2024
Our researchers will be in Vienna this week to showcase AutoCRAT findings and results. University of Gothenburg's Dr Kristina Vukusic's poster (#450) titled "Efficacy of Intra-articular Injections of human induced Mesenchymal Stem Cells, Extracellular Vesicles, [...]
Fraunhofer IPT hosts the AutoCRAT consortium’s final meeting
Partners assembled in Aachen, Germany from all points of Europe to meet AutoCRAT partners for the final plenary meeting. The two-day gathering took place on April 11th and 12th, 2024. Special thanks to Ferdinand Groten [...]